Fol. Biol. 2012, 58, 16-23
https://doi.org/10.14712/fb2012058010016
TRAF2 Docking with Related Proteins in Silico Studies
References
1. 2008) Smurf2 is a TRAF2 binding protein that triggers TNF-R2 ubiquitination and TnF-R2-induced JnK activation. Biochem. Biophys. Res. Commun. 374, 752-757.
< , I., Coornaert, B., Beyaert, R. (https://doi.org/10.1016/j.bbrc.2008.07.103>
2. 2008) Tumor suppressor CYLD: negative regulation of NF-κB signaling and more. Cell. Mol. Life Sci. 65, 1123-1132.
< , G. (https://doi.org/10.1007/s00018-007-7465-4>
3. 2010) HSP70 interacts with TRAF2 and differentially regulates TNFα signalling in human colon cancer cells. J. Cell. Mol. Med. 14, 710-725.
< , S., Jiang, L., Wang, G., Zhou, X., Wei, X., Cheng, H., Wu, Z., Wei, D. (https://doi.org/10.1111/j.1582-4934.2009.00716.x>
4. 1997) CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev. 11, 2810-2821.
< , C. S., Thompson, C. B. (https://doi.org/10.1101/gad.11.21.2810>
5. 2007) Protein-protein interactions in TRAF3. Adv. Exp. Med. Biol. 597, 114-121.
< , K. R., Kodandapani, R., Wu, S. (https://doi.org/10.1007/978-0-387-70630-6_9>
6. 2011) Deletion of ciAP1 and ciAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. Blood 117, 4041-4051.
< , S., Turner, V. M., Anderton, H., Limaye, S., Basten, A., Koentgen, F., Vaux, D. L., Silke, J., Brink, R. (https://doi.org/10.1182/blood-2010-10-312793>
7. 2003) Detection of a functional hybrid receptor γc/GM-CSFRβ in human hematopoietic CD34+ cells. J. Exp. Med. 197, 763-775.
< , J., Fogli, M., Gaggero, A., Ferrini, S., Caignard, A., Brouty-Boye, D., Baouz, S., Le Bousse-Kerdiles, M. C., Peault, B., van Dijk, M., Bulfone-Paus, S., Durali, D., Chouaib, S., Azzarone, B. (https://doi.org/10.1084/jem.20020150>
8. 2004) Protein kinase PKN1 associates with TRAF2 and is involved in TRAF2-NF-κB signaling pathway. Biochem. Biophys. Res. Commun. 314, 688-694.
< , Y., Oishi, K., Shibata, H., Yamagiwa, A., Isagawa, T., Nishimura, T., Goyama, E., Takahashi, M., Mukai, H., Ono, Y. (https://doi.org/10.1016/j.bbrc.2003.12.148>
9. 2009) Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1. J. Immunol. 183, 2966-2973.
< , J. P., Moore, C. R., Bishop, G. A. (https://doi.org/10.4049/jimmunol.0900442>
10. 2004) TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-κB activation. J. Biol. Chem. 279, 55855-55865.
< , L., Grammer, A. C., Wu, X., Lipsky, P. E. (https://doi.org/10.1074/jbc.M407284200>
11. 2007) Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat. Immunol. 8, 504-513.
< , S., Lim, S., Li, A. G., Lee, C., Lee, Y. S., Lee, E. K., Park, S. H., Wang, X. J., Kim, S. J. (https://doi.org/10.1038/ni1451>
12. 2010) MINK and TNIK differentially act on Rap2-mediated signal transduction to regulate neuronal structure and AMPA receptor function. J. Neurosci. 30, 14786-14794.
< , N. K., Hsin, H., Huganir, R. L., Sheng, M. (https://doi.org/10.1523/JNEUROSCI.4124-10.2010>
13. 2007) Tumor necrosis factor receptor-1 can function through a G αq/11-β-arrestin-1 signaling complex. J. Biol. Chem. 282, 28549-28556.
< , Y., imamura, T., Babendure, J. L., Lu, J. C., Yoshizaki, T., olefsky, J. M. (https://doi.org/10.1074/jbc.M705869200>
14. 2008) Identification of MAVS splicing variants that interfere with Rigi/MAVS pathway signaling. Mol. Immunol. 45, 2277-2287.
< , S. P., Yang, G., Scott, D. A., Chao, T. H., Correia Jda, S., de la Torre, J. C., Li, E. (https://doi.org/10.1016/j.molimm.2007.11.018>
15. 2009) Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-κB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy. J. Biol. Chem. 284, 4439-4450.
< , H., Mittal, A., Paul, P. K., Kumar, M., Srivastava, D. S., Tyagi, S. C., Kumar, A. (https://doi.org/10.1074/jbc.M805546200>
16. 2009) Differential activation of JNK1 isoforms by TRAIL receptors modulates apoptosis of colon cancer cell lines. Br. J. Cancer. 100, 1415-1424.
< , D., Keane, M., Pirianov, G., Mehmet, H., Samali, A., Szegezdi, E. (https://doi.org/10.1038/sj.bjc.6605021>
17. 2009) RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1. J. Biol. Chem. 284, 10774-10782.
< , S. S., Jensen, S. B., Chiliveru, S., Melchjorsen, J., Julkunen, I., Gaestel, M., Arthur, J. S., Flavell, R. A., Ghosh, S., Paludan, S. R. (https://doi.org/10.1074/jbc.M807272200>
18. 1999) NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 18, 6694-6704.
< , J. L., Baltimore, D. (https://doi.org/10.1093/emboj/18.23.6694>
19. 2008) Recent progress and future directions in protein-protein docking. Curr. Protein Pept. Sci. 9, 1-15.
< , D. W. (https://doi.org/10.2174/138920308783565741>
20. 2008) Accelerating protein-protein docking correlations using a six-dimensional analytic FFT generating function. Bioinformatics 24, 1865-1873.
< , D. W., Kozakov, D., Vajda, S. (https://doi.org/10.1093/bioinformatics/btn334>
21. 2008) SH-5, an AKT inhibitor potentiates apoptosis and inhibits invasion through the suppression of anti-apoptotic, proliferative and metastatic gene products regulated by IκBα kinase activation. Biochem. Pharmacol. 76, 1404-1416.
< , G., Ahn, K. S., Sung, B., Kunnumakkara, A. B., Chaturvedi, M. M., Aggarwal, B. B. (https://doi.org/10.1016/j.bcp.2008.05.023>
22. 2010) Inhibition of NFκB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327, 1135-1139.
< , N., Ma, A., Harhaj, E. W. (https://doi.org/10.1126/science.1182364>
23. 2009) TRAF2 interacts with Smad4 and regulates BMP signaling pathway in MC3T3-e1 osteoblasts. Biochem. Biophys. Res. Commun. 390, 775-779.
< , K., Ikeda, K., Ito, K. (https://doi.org/10.1016/j.bbrc.2009.10.048>
24. 2000) Solution structure of n-TRADD and characterization of the interaction of n-TRADD and C-TRAF2, a key step in the TnFR1 signaling pathway. Mol. Cell. 5, 1051-1057.
< , D. H., McDonagh, T., Telliez, J. B., Hsu, S., Malakian, K., Xu, G. Y., Lin, L. L. (https://doi.org/10.1016/S1097-2765(00)80270-1>
25. 2009) Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1-TNFR2 cooperation. Oncogene 28, 1769-1781.
< , A., Henkler, F., Salzmann, S., Scheurich, P., Kneitz, C, Wajant, H. (https://doi.org/10.1038/onc.2009.29>
26. 1999) TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J. Biol. Chem. 274, 30202-30208.
< , X., Mehlen, P., Rabizadeh, S., VanArsdale, T., Zhang, H., Shin, H., Wang, J. J., Leo, E., Zapata, J., Hauser, C. A., Reed, J. C., Bredesen, D. E. (https://doi.org/10.1074/jbc.274.42.30202>
27. 2004) Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene 23, 2009-2015.
< , H. G., Wang, J., Yang, X., Hsu, H. C., Mountz, J. D. (https://doi.org/10.1038/sj.onc.1207373>